Stock TWST TWIST BIOSCIENCE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Twist Bioscience Corporation

Equities

TWST

US90184D1000

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
50.99 USD +0.97% Intraday chart for Twist Bioscience Corporation +6.23% +38.33%
Jul. 09 Goldman Sachs Raises Price Target on Twist Bioscience to $55 From $45, Maintains Buy Rating MT
Jul. 09 Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies
BU
Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A
BU
Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
BU
Twist Bioscience : June 2024 Corporate Deck
PU
Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
BU
Twist Bioscience to Present at Upcoming Investor Conferences
BU
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
BU
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(4)
AQ
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BU
Twist Bioscience : Fiscal 2024 2Q Financial Results
PU
Twist Bioscience: Fiscal Q2 Earnings Snapshot
AQ
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
BU
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
BU
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
BU
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
BU
Twist Bioscience to Present at Upcoming Investor Conferences
BU
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(4)
AQ
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BU
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
BU
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TWST Stock
  4. News Twist Bioscience Corporation
  5. Press Releases